V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20212145 | 20078834 | null | null | Neo-adjuvant (N) | 2018-04-13 | 2018-05-04 | Doxorubicin chemoembolisation | 99 | Y | DOXORUBICIN EMBOLISATION | 101475422 |
| 20212146 | 20078835 | 1.62 | 62.5 | Palliative (P) | 2017-07-31 | 2017-08-05 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100170397 |
| 20212148 | 20078836 | 1.71 | 91.4 | Palliative (P) | 2017-10-13 | 2017-11-01 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 101389036 |
| 20212150 | 20078837 | 1.55 | null | null | 2018-07-25 | 2018-07-25 | Capecitabine (21days) + Carboplatin | 2 | null | CISPLATIN + FLUOROURACIL | 100599325 |
| 20212151 | 20078838 | 1.66 | 135 | Palliative (P) | 2018-08-07 | 2018-08-07 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101775093 |
| 20212153 | 20078839 | 1.57 | 80.4 | Neo-adjuvant (N) | 2018-12-12 | 2018-12-18 | CISPLATIN + FLUOROURACIL + RT | 02 | N | CISPLATIN + FLUOROURACIL | 101829390 |
| 20212154 | 20078840 | 1.56 | 55.4 | Curative (C) | 2017-08-26 | 2017-08-27 | Trial Unspecified | 01 | Y | TRIAL UNSPECIFIED | 101196068 |
| 20212156 | 20078841 | 1.65 | 96.2 | Palliative (P) | 2016-07-10 | 2016-07-14 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100212375 |
| 20212157 | 20078842 | 1.69 | 87.1 | Adjuvant (A) | 2018-05-08 | 2018-05-08 | Cisplatin +Fluorouracil (3 wk) | 02 | Y | CISPLATIN + FLUOROURACIL | 101281213 |
| 20212158 | 20078843 | 1.52 | 81 | Neo-adjuvant (N) | 2019-03-16 | 2019-03-31 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 101611424 |
| 20212159 | 20078844 | 1.56 | 82.4 | Palliative (P) | 2017-08-18 | 2017-08-18 | Capecitabine (21days) + Carboplatin | N | null | TRIAL UNSPECIFIED | 100016305 |
| 20212160 | 20078845 | 1.66 | 85.4 | Neo-adjuvant (N) | 2018-09-03 | 2018-10-04 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101431698 |
| 20212162 | 20078846 | 1.77 | 83.8 | Palliative (P) | 2018-04-23 | 2018-05-13 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100304192 |
| 20212163 | 20078847 | 1.76 | 68.3 | Curative (C) | 2018-02-12 | 2018-02-12 | Trial Unspecified | 01 | Y | TRIAL UNSPECIFIED | 100981133 |
| 20212164 | 20078848 | 1.78 | 136.4 | Palliative (P) | 2017-12-22 | 2018-03-03 | Doxorubicin chemoembolisation | null | N | DOXORUBICIN EMBOLISATION | 100046816 |
| 20212165 | 20078849 | 1.78 | 57.8 | Palliative (P) | 2019-02-26 | 2019-03-17 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100602016 |
| 20212166 | 20078850 | 1.85 | 57.3 | Curative (C) | 2018-03-24 | 2018-04-06 | Cisplatin +Fluorouracil (3 wk) | N | Y | CISPLATIN + FLUOROURACIL | 100807243 |
| 20212167 | 20078851 | 1.74 | 59.3 | Neo-adjuvant (N) | 2018-07-14 | 2018-08-05 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101006412 |
| 20212170 | 20078852 | 1.6 | 98.8 | Palliative (P) | 2019-05-30 | 2019-06-05 | Cisplatin +Fluorouracil (2 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100411649 |
| 20212171 | 20078853 | 1.72 | 54.1 | Palliative (P) | null | 2018-03-30 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101159462 |
| 20212172 | 20078854 | 1.74 | 74 | Palliative (P) | 2019-08-29 | 2019-09-28 | Cisplatin +Fluorouracil (3 wk) | 02 | null | CISPLATIN + FLUOROURACIL | 101366351 |
| 20212174 | 20078855 | 1.79 | 52.4 | Curative (C) | 2017-10-19 | 2017-10-20 | Capecitabine (21days) + Carboplatin | 02 | N | TRIAL UNSPECIFIED | 101835548 |
| 20212176 | 20078856 | 1.55 | 80 | 03 | 2018-09-10 | 2018-09-28 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 100785556 |
| 20212177 | 20078857 | 1.66 | 68.1 | Palliative (P) | 2018-01-23 | 2018-02-10 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 101858302 |
| 20212178 | 20078858 | 0 | 0 | Palliative (P) | 2016-12-10 | 2016-12-26 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101170886 |
| 20212179 | 20078859 | 1.61 | 60.3 | Adjuvant (A) | 2018-10-21 | 2018-10-22 | Capecitabine (21days) + Carboplatin | N | N | CAPECITABINE + CARBOPLATIN | 100460579 |
| 20212181 | 20078860 | 1.82 | 77.9 | Palliative (P) | 2019-05-04 | 2019-05-07 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100333811 |
| 20212182 | 20078861 | 1.67 | 44.15 | null | 2019-09-20 | 2019-09-20 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 101771917 |
| 20212184 | 20078862 | 1.6 | 93.8 | Neo-adjuvant (N) | 2019-08-17 | 2019-09-06 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 101699749 |
| 20212185 | 20078863 | 1.81 | 49 | Neo-adjuvant (N) | 2018-12-02 | 2018-12-07 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100445216 |
| 20212186 | 20078864 | 1.65 | 99 | Palliative (P) | 2017-08-14 | 2017-08-18 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101269498 |
| 20212187 | 20078865 | 0 | 52.95 | null | 2019-05-05 | 2019-05-05 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100359204 |
| 20212189 | 20078866 | 1.78 | 80.8 | Palliative (P) | 2016-07-13 | 2016-07-14 | Capecitabine (21days) + Carboplatin | 02 | Y | TRIAL UNSPECIFIED | 100914396 |
| 20212190 | 20078867 | 1.69 | 78 | Neo-adjuvant (N) | 2020-01-29 | 2020-02-24 | Cisplatin +Fluorouracil (3 wk) | 02 | null | CISPLATIN + FLUOROURACIL | 100065718 |
| 20212191 | 20078868 | 1.68 | 86 | Palliative (P) | 2016-04-11 | 2016-04-11 | CISPLATIN + FLUOROURACIL | 02 | N | CAPECITABINE + CARBOPLATIN | 100990268 |
| 20212192 | 20078869 | 1.71 | 58.15 | Palliative (P) | 2018-06-30 | 2018-09-21 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100384223 |
| 20212193 | 20078870 | 1.73 | 47 | Palliative (P) | 2018-04-28 | 2018-05-07 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100754571 |
| 20212194 | 20078871 | 1.57 | 54.8 | Palliative (P) | 2019-12-02 | 2019-12-03 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101539571 |
| 20212195 | 20078872 | 1.45 | 67.4 | Neo-adjuvant (N) | 2016-10-12 | 2016-10-23 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100551260 |
| 20212196 | 20078873 | 0 | 0 | null | 2018-08-05 | 2018-09-27 | Doxorubicin chemoembolisation | N | null | DOXORUBICIN EMBOLISATION | 100958897 |
| 20212199 | 20078874 | 1.76 | 89.9 | Palliative (P) | 2016-04-12 | 2016-04-12 | Trial Unspecified | null | N | TRIAL UNSPECIFIED | 101173949 |
| 20212200 | 20078875 | 1.75 | 114.1 | Palliative (P) | 2021-12-27 | 2021-12-27 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101128574 |
| 20212201 | 20078876 | 1.63 | 67 | Neo-adjuvant (N) | 2018-03-25 | 2018-03-25 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100186421 |
| 20212202 | 20078877 | 1.66 | 66.6 | Curative (C) | 2018-09-28 | 2018-09-29 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 101246487 |
| 20212203 | 20078878 | 1.72 | 68.4 | Palliative (P) | 2019-11-27 | 2019-12-12 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100306287 |
| 20212204 | 20078879 | 1.76 | 56.6 | Palliative (P) | 2017-06-14 | 2017-06-29 | CISPLATIN + FLUOROURACIL + RT | 02 | null | CISPLATIN + FLUOROURACIL | 101119606 |
| 20212205 | 20078880 | 1.87 | 61.4 | Neo-adjuvant (N) | 2016-10-07 | 2016-10-25 | Cisplatin +Fluorouracil (3 wk) | N | N | CISPLATIN + FLUOROURACIL | 101424227 |
| 20212206 | 20078881 | 1.77 | 110.7 | 03 | 2018-10-03 | 2018-10-22 | CAPECITABINE + CARBOPLATIN | 02 | N | TRIAL UNSPECIFIED | 100181657 |
| 20212207 | 20078882 | 1.77 | 82.4 | Palliative (P) | 2016-10-30 | 2016-10-30 | Capecitabine (21days) + Carboplatin | 02 | N | TRIAL UNSPECIFIED | 100585277 |
| 20212209 | 20078883 | 1.77 | 87 | Neo-adjuvant (N) | 2018-08-15 | 2018-09-02 | CAPECITABINE + CARBOPLATIN | 02 | N | CISPLATIN + FLUOROURACIL | 101295304 |